Showing results (631-640 of 712) with videos related to

Sort By:
Pageof 72
Cell Chemical Biology|May 18, 2016
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and PathogenicitySharon M Louie, Elizabeth A Grossman, Lisa A Crawford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochlorideStuart A Grossman, Kathryn A Carson, Tracy T Batchelor, et al.
Clinical Endocrinology|April 1, 1993
Malignant prolactinoma with extracranial metastases: a report of three casesJ D Walker, A Grossman, J V Anderson, et al.
Neuro-Oncology|January 19, 2013
NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiformeDavid M Peereboom, Manmeet S Ahluwalia, Xiaobu Ye, et al.
Cancer Genetics and Cytogenetics|October 15, 1988
The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemiaM E Weinstein, A Grossman, M A Perle, et al.
Transplantation|August 1, 1985
The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantationM L Smiley, C G Wlodaver, R A Grossman, et al.
Cancer|January 1, 1993
Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancerL P Pertschuk, J G Feldman, D S Kim, et al.
Frontiers in Medicine|December 25, 2023
Druggable genomic landscapes of high-grade gliomasPaola Ghanem, Maria Fatteh, David Olayinka Kamson, et al.
Transplantation|August 1, 1992
A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorderE J Alfrey, A L Friedman, R A Grossman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trialJon Weingart, Stuart A Grossman, Kathryn A Carson, et al.
Pageof 72